Clear Street’s Strata Critical Medical Inc Warrants SRTAW Stock Holding History

Clear Street’s Portfolio SRTAW Stock Details SRTAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-279	Closed	-$1	–	1399
2026 Q1	$1	Buy	279 +179	+179%	+$14	﹤0.01%	1102
2025 Q4	$11	Buy	+100	New	+$17	﹤0.01%	918

Clear Street's SRTAW Position: Q2 2026 in Review

Clear Street sold out of Strata Critical Medical Inc Warrants (SRTAW) in Q2 2026, closing a stake of 279 shares — an estimated $1 sold.

Clear Street first reported a position in SRTAW in Q4 2025 and held it in 2 quarters. The position peaked at $11 in Q4 2025. 0 funds tracked by Wall St. Rank hold SRTAW as of Q2 2026.

Clear Street reported no remaining Strata Critical Medical Inc Warrants position as of Q2 2026 after selling out during the quarter.
Clear Street sold 279 Strata Critical Medical Inc Warrants shares in Q2 2026, an estimated $1.
Clear Street first reported a position in Strata Critical Medical Inc Warrants in Q4 2025 and held it in 2 quarters.
Clear Street's Strata Critical Medical Inc Warrants position peaked at $11 in Q4 2025.
0 funds tracked by Wall St. Rank held Strata Critical Medical Inc Warrants as of Q2 2026.

Based on Clear Street's 13F filing for Q2 2026, filed 12 Aug 2026.